Payment overview · 2025
General Payments
$69.17
4 reported records · 3 companies
Healthcare provider profile · identity verified
Lewis Roy King, MD
Allopathic & Osteopathic Physicians|Family Medicine · GILMER, TX · NPI 1841293487
Verified facts
What the public records show
CMS Open Payments records show Lewis Roy King, MD received $69.17 in general payments during 2025 across 4 reported records.
Kowa Pharmaceuticals America, Inc. accounted for 55.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 102 claims for Mounjaro by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $38.44 | 55.6% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $16.05 | 23.2% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $14.68 | 21.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $69.17 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $38.44 | 2 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $16.05 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $14.68 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $14.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 102 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
58 | 12 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
102 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 796 | 164 |
| Levothyroxine Sodium | Levothyroxine Sodium | 597 | 113 |
| Amlodipine Besylate | Amlodipine Besylate | 551 | 115 |
| Lisinopril | Lisinopril | 521 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 512 | 100 |
| Losartan Potassium | Losartan Potassium | 484 | 100 |
| Gabapentin | Gabapentin | 480 | 93 |
| Potassium Chloride | Potassium Chloride | 449 | 103 |
| Metformin Hcl | Metformin Hcl | 443 | 85 |
| Omeprazole | Omeprazole | 433 | 88 |
| Metoprolol Succinate | Metoprolol Succinate | 418 | 86 |
| Alprazolam | Alprazolam | 409 | 58 |
| Meloxicam | Meloxicam | 355 | 83 |
| Furosemide | Furosemide | 321 | 78 |
| Tramadol Hcl | Tramadol Hcl | 320 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 310 | 58 |
| Clopidogrel | Clopidogrel Bisulfate | 299 | 55 |
| Temazepam | Temazepam | 281 | 41 |
| Levofloxacin | Levofloxacin | 264 | 165 |
| Montelukast Sodium | Montelukast Sodium | 261 | 61 |
| Pioglitazone Hcl | Pioglitazone Hcl | 261 | 49 |
| Felodipine Er | Felodipine | 253 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 249 | 55 |
| Prednisone | Prednisone | 232 | 145 |
| Valsartan | Valsartan | 226 | 40 |
| Lorazepam | Lorazepam | 216 | 45 |
| Sertraline Hcl | Sertraline Hcl | 215 | 46 |
| Terazosin Hcl | Terazosin Hcl | 212 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 211 | 47 |
| Simvastatin | Simvastatin | 204 | 43 |
| Eliquis | Apixaban | 203 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 193 | 137 |
| Metoprolol Tartrate | Metoprolol Tartrate | 185 | 41 |
| Celecoxib | Celecoxib | 180 | 43 |
| Metformin Hcl Er | Metformin Hcl | 175 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 171 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 169 | 40 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 163 | 115 |
| Duloxetine Hcl | Duloxetine Hcl | 163 | 30 |
| Atenolol | Atenolol | 162 | 26 |
| Diclofenac Sodium | Diclofenac Sodium | 160 | 33 |
| Allopurinol | Allopurinol | 156 | 33 |
| Famotidine | Famotidine | 149 | 37 |
| Ropinirole Hcl | Ropinirole Hcl | 141 | 22 |
| Carvedilol | Carvedilol | 140 | 33 |
| Clonazepam | Clonazepam | 135 | 20 |
| Donepezil Hcl | Donepezil Hcl | 129 | 21 |
| Alendronate Sodium | Alendronate Sodium | 128 | 29 |
| Amoxicillin | Amoxicillin | 128 | 97 |
| Januvia | Sitagliptin Phosphate | 127 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 121 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 121 | 19 |
| Buspirone Hcl | Buspirone Hcl | 120 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 118 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 118 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 117 | 42 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 116 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 116 | 28 |
| Ozempic | Semaglutide | 115 | 20 |
| Mirtazapine | Mirtazapine | 111 | 18 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 105 | 34 |
| Topiramate | Topiramate | 104 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 102 | 19 |
| Mounjaro | Tirzepatide | 102 | 14 |
| Estradiol | Estradiol | 97 | 20 |
| Trazodone Hcl | Trazodone Hcl | 97 | 19 |
| Nifedipine Er | Nifedipine | 94 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 93 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 91 | 25 |
| Azithromycin | Azithromycin | 88 | 58 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 88 | 36 |
| Klor-Con M20 | Potassium Chloride | 86 | 23 |
| Spironolactone | Spironolactone | 86 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 83 | 12 |
| Glimepiride | Glimepiride | 82 | 23 |
| Tizanidine Hcl | Tizanidine Hcl | 82 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 40 |
| Clonidine Hcl | Clonidine Hcl | 79 | 21 |
| Cephalexin | Cephalexin | 78 | 55 |
| Dicyclomine Hcl | Dicyclomine Hcl | 69 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 69 | 18 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 69 | 53 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 68 | 21 |
| Fluconazole | Fluconazole | 67 | 34 |
| Ezetimibe | Ezetimibe | 66 | 14 |
| Pregabalin | Pregabalin | 65 | suppressed |
| Sucralfate | Sucralfate | 64 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 62 | 14 |
| Glipizide Er | Glipizide | 61 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 60 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 59 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 58 | 11 |
| Jardiance | Empagliflozin | 58 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 57 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 56 | 18 |
| Diazepam | Diazepam | 54 | 12 |
| Torsemide | Torsemide | 53 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 53 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 52 | suppressed |
| Linzess | Linaclotide | 52 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 50 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 50 | suppressed |
| Synthroid | Levothyroxine Sodium | 50 | 15 |
| Acyclovir | Acyclovir | 49 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 49 | suppressed |
| Glipizide | Glipizide | 48 | suppressed |
| Memantine Hcl | Memantine Hcl | 48 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 46 | 20 |
| Cholestyramine | Cholestyramine (With Sugar) | 46 | suppressed |
| Carisoprodol | Carisoprodol | 45 | suppressed |
| Nabumetone | Nabumetone | 45 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 45 | 35 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 34 |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 43 | suppressed |
| Finasteride | Finasteride | 41 | suppressed |
| Verapamil Sr | Verapamil Hcl | 41 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 40 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 37 | 27 |
| Primidone | Primidone | 37 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 29 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 29 |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Lactulose | Lactulose | 34 | 13 |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Naproxen | Naproxen | 34 | suppressed |
| Baclofen | Baclofen | 33 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Famciclovir | Famciclovir | 31 | 22 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 30 | 30 |
| Dexamethasone | Dexamethasone | 30 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Metolazone | Metolazone | 29 | 11 |
| Repatha Sureclick | Evolocumab | 29 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Mupirocin | Mupirocin | 27 | 24 |
| Lovastatin | Lovastatin | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Nystatin | Nystatin | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 24 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Clonidine | Clonidine | 22 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 19 |
| Lagevrio (Eua) | Molnupiravir | 21 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 21 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Niacin Er | Niacin | 19 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | 14 |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 18 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Clarithromycin | Clarithromycin | 16 | 15 |
| Erythromycin | Erythromycin Base | 16 | 15 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Nadolol | Nadolol | 16 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Zonisamide | Zonisamide | 16 | suppressed |
| Eszopiclone | Eszopiclone | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 13 |
| Cefdinir | Cefdinir | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Cosentyx Syringe | Secukinumab | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 14 | 14 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Ssd | Silver Sulfadiazine | 14 | 13 |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Constulose | Lactulose | 13 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Triazolam | Triazolam | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Cefadroxil | Cefadroxil | 12 | 11 |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | 11 |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $69.17 · 4 records | Kowa Pharmaceuticals America, Inc. | EVENITY, MOUNJARO, ZEPBOUND, ZORYVE | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error